| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $68.7M | +41.0% |
| R&D Expense | $59.6M | +11.6% |
| SG&A Expense | $35.3M | -9.7% |
| Operating Income | -$26.2M | +40.2% |
| Interest Expense | $1.8M | -20.1% |
| Net Income | $7.2M | +111.7% |
| EPS (Basic) | $1.05 | +106.6% |
| EPS (Diluted) | $1.04 | +106.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $85.9M | -26.4% |
| Short-term Investments | $413K | — |
| Accounts Receivable | $229K | -74.6% |
| Current Assets | $95.0M | -30.3% |
| Total Assets | $136.4M | -14.6% |
| Current Liabilities | $15.0M | -70.0% |
| Total Liabilities | $80.0M | -43.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.4M | +30.5% |
| Investing Cash Flow | -$215K | -103.7% |
| Financing Cash Flow | $50.5M | +836.5% |
| Stockholders' Equity |
| $56.4M |
| +199.0% |